This inventor holds 2 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Kyushu University, Kowa Company Limited. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 455 
1 out of 605 
Years Active: 2010-2019
Title: Innovations by Tatsuro Ishibashi
Introduction
Tatsuro Ishibashi is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Ishibashi's work focuses on therapeutic agents and staining compositions for ocular diseases.
Latest Patents
Ishibashi's latest patents include a therapeutic agent for ocular fundus disease. This agent is particularly aimed at treating diabetic retinopathy and age-related macular degeneration. The active ingredient in this agent is (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, along with its salts or solvates. Another significant patent is a staining composition designed for staining an ophthalmic membrane during removal procedures. This composition utilizes a Brilliant Blue G (BBG) derivative as its primary component.
Career Highlights
Throughout his career, Ishibashi has worked with esteemed institutions such as Kyushu University and Kowa Company Limited. His work in these organizations has allowed him to develop and refine his innovative ideas in the field of ophthalmology.
Collaborations
Ishibashi has collaborated with notable colleagues, including Shintaro Nakao and Akifumi Tsuchiura. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Tatsuro Ishibashi's contributions to ophthalmology through his patents demonstrate his commitment to improving treatments for ocular diseases. His innovative work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile